Svetlana Nikic, Founder of Precision Oncology Consulting, shared on LinkedIn:
“Here’s my shortlist – sessions that I’ll attend at this year’s ESMO26 in Madrid.
What are the sessions you’re most looking forward to and would recommend me not to miss?
My Top 3 Picks
1. Liquid biopsies in early drug development
Time: Fri 23 Oct., 16:15–17:00
Location: Malaga, Hall 3
2. Overcoming barriers of access to clinical trials
Time: Sat 24 Oct., 08:30–10:00
Location: Seville, NCC
3. Is HRD the next tumour-agnostic target?
Time: Sat 24 Oct., 14:45–15:30
Location: Pamplona, Hall 5
Friday 23 October
(ESMO 2026, Dat 1 Of 3)
- 11:30–13:00 | ESMO Presidential address
Location: Alicante, Hall 6
- 13:30–15:00 | Clinical benefit in a changing trial landscape
Location: Oviedo, Hall 5
- 16:15–17:00 | Liquid biopsies in early drug development
Location: Malaga, Hall 3
- 16:15–17:45 | Raising the bar for tumour-agnostic studies
Location: Cordoba, Hall 4
Saturday 24 October
(ESMO 2026, Day 2 Of 3)
- 08:30–10:00 | AI and real-world data: ESMO frameworks
Location: Oviedo, Hall 5
- 08:30–10:00 | Overcoming barriers of access to clinical trials
Location: Seville, NCC
- 10:15–11:45 | Beyond guidelines: Grey zones of oncology practice
Location: Murcia, Hall 3
- 13:00–14:30 | Access, equity, and reducing inequalities
Location: Seville, NCC
- 14:45–15:30 | Is HRD the next tumour-agnostic target?
Location: Pamplona, Hall 5
- 14:45–15:45 | Drugging the undruggables
Location: Santander, Hall 10
Sunday 25 October
(ESMO 2026, Day 3 Of 3)
- 08:30–10:00 | ctDNA in colorectal cancer: Clinical applications
Location: Burgos, Hall 3
- 14:45–16:15 | Accessible cancer care for everyone, everywhere
Location: Seville, NCC
- 16:30–18:15 | Presidential Symposium II
Location: Alicante, Hall 6
Other articles about ESMO26 on OncoDaily.